Comparison of the risk of infections in different anti-TNF agents: a meta-analysis-Reference-Cited by-同舟云学术

Comparison of the risk of infections in different anti-TNF agents: a meta-analysis

Published:2017-02 Issue:2 Volume:20 Page:161-168
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J Rheum Dis

Author:

Liao Hongxing¹²,Zhong Zhixiong¹,Liu Zhanliang¹,Zou Xuenong²

Affiliation:

1. Division of Joint Surgery; Orthopedic Department; The Meizhou People's Hospital; Meizhou Guangdong China

2. Guangdong Provincial Key Laboratory of Orthopedics and Traumatology; The First Affiliated Hospital of Sun Yat-sen University; Guangzhou Guangdong China

Funder

Natural Science Foundation of Guangdong Province

National Natural Science Foundation of China

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1756-185X.12970/fullpdf

Reference31 articles.

1. Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry;Atzeni;Autoimmun Rev,2012

2. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation;Banner;Cell,1993

3. Treatment of rheumatoid arthritis with anti-TNF-alpha agents: a reappraisal;Caporali;Autoimmun Rev,2009

4. Infections associated with tumor necrosis factor-alpha antagonists;Crum;Medicine (Baltimore),2005

5. Infections and biological therapy in rheumatoid arthritis;Cunnane;Best Pract Res Clin Rheumatol,2003

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biologics Versus JAK Inhibitors. Part II: Risk of Infections. A Narrative Review;Dermatology and Therapy;2024-07-16

2. The risk of tuberculosis infection in Saudi patients receiving adalimumab, etanercept, and tocilizumab therapy;Journal of Infection and Public Health;2024-06

3. Poor Translatability of Biomedical Research Using Animals — A Narrative Review;Alternatives to Laboratory Animals;2023-03

4. First-time adverse drug reactions, survival analysis, and the share of adverse drug reactions in treatment discontinuation in real-world rheumatoid arthritis patients: a comparison of first-time treatment with adalimumab and etanercept;Expert Opinion on Drug Safety;2023-01-27

5. Clinical outcomes and prognostic factors of bronchiectasis rheumatoid overlap syndrome: A multi-institution cohort study;Frontiers in Medicine;2022-10-13